{"id":53578,"date":"2023-02-02T16:03:27","date_gmt":"2023-02-02T15:03:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/"},"modified":"2023-02-02T16:03:27","modified_gmt":"2023-02-02T15:03:27","slug":"applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/","title":{"rendered":"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023"},"content":{"rendered":"<div>\n<p>STONY BROOK, N.Y.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24APDN&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$APDN<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/LinearDNA?src=hash\" target=\"_blank\" rel=\"noopener\">#LinearDNA<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.adnas.com&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=Applied+DNA+Sciences%2C+Inc.&amp;index=1&amp;md5=4412bd9ccb765abb21e2eb9b36f7e3be\" rel=\"nofollow noopener\" shape=\"rect\">Applied DNA Sciences, Inc.<\/a> (NASDAQ: APDN) (\u201cApplied DNA\u201d or the \u201cCompany\u201d), a leader in polymerase chain reaction (&#8220;PCR&#8221;)-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023. The Company will host a conference call for the investment community to discuss its results and answer questions at 4:30 p.m. ET.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230202005522\/en\/593924\/5\/box-logo-businesswire.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230202005522\/en\/593924\/21\/box-logo-businesswire.jpg\"><\/a><\/p>\n<p>\n<b><span class=\"bwuline\">Date &amp; Time:<\/span><\/b> Thursday, February 9 @ 4:30 p.m. ET\n<\/p>\n<p>\nDial In (ask to be joined into the Applied DNA Sciences call):\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nDomestic callers (toll free): 844-887-9402\n<\/li>\n<li>\nCanadian callers (toll free): 866-605-3852\n<\/li>\n<li>\nInternational callers: 412-317-6798\n<\/li>\n<li>\nLive webcast: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.choruscall.com%2Fmediaframe%2Fwebcast.html%3Fwebcastid%3DgZ93PCbr&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.choruscall.com%2Fmediaframe%2Fwebcast.html%3Fwebcastid%3DgZ93PCbr&amp;index=2&amp;md5=140d5591d25fd14fdb93cde07c65f821\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=gZ93PCbr<\/a>\n<\/li>\n<\/ul>\n<p>\nA telephonic replay of the conference call will be available for 1 week following the conclusion of the live call:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nReplay for domestic callers (toll free): 877-344-7529, replay access code 2079390\n<\/li>\n<li>\nReplay for Canadian callers: 855-669-9658, replay access code 2079390\n<\/li>\n<\/ul>\n<p>\nAn archived webcast replay of the conference call will be available for 1 year following the conclusion of the live call: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.choruscall.com%2Fmediaframe%2Fwebcast.html%3Fwebcastid%3DgZ93PCbr&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.choruscall.com%2Fmediaframe%2Fwebcast.html%3Fwebcastid%3DgZ93PCbr&amp;index=3&amp;md5=404647963dc6fd9485d6716e4a66eab5\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=gZ93PCbr<\/a>\n<\/p>\n<p>\nAn accompanying slide presentation will be embedded in the webcast (live and replay) and can also be accessed in the \u2018<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adnas.com%2Fnews-events%2Fcompany-events%2F&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=Company+Events&amp;index=4&amp;md5=fe51e0d0ce2053a9a28a8b166042e050\" rel=\"nofollow noopener\" shape=\"rect\">Company Events<\/a>\u2019 section of the \u2018News &amp; Events\u2019 tab of the Applied DNA investor relations website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adnas.com%2F&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adnas.com%2F&amp;index=5&amp;md5=1dceb2086162b9faacb40c58ee90ecec\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/investors.adnas.com\/<\/a>.\n<\/p>\n<p>\n<b>About Applied DNA Sciences<\/b>\n<\/p>\n<p>\nApplied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid (&#8220;DNA&#8221;). Using the polymerase chain reaction (&#8220;PCR&#8221;) to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.\n<\/p>\n<p>\nVisit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.adnas.com%2F&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=adnas.com&amp;index=6&amp;md5=730ca3ddc39d2e096dc1f56a0536f81f\" rel=\"nofollow noopener\" shape=\"rect\">adnas.com <\/a>for more information. Follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FAPDN&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=Twitter&amp;index=7&amp;md5=653cb5eea34b54f817b1d5bf3c78ca1c\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fapplied-dna-sciences%2F&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=8&amp;md5=502effe8e6fe7bfcdd1989152277dc7c\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>. Join our <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvisitor.r20.constantcontact.com%2Fmanage%2Foptin%3Fv%3D001WY2H_3RLHWpUIP7uJ0g2FUYlX7COpyndjr_yah9C58ngZJ6ahj8DbNSztyPn7vIMqLYeA-liYQt3MpvUE8gyvu4plzwyyCepelE65zAbhN8%253D&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=mailing+list&amp;index=9&amp;md5=83a8e294bbf74c1777ed2f9c7fd8feb2\" rel=\"nofollow noopener\" shape=\"rect\">mailing list<\/a>.\n<\/p>\n<p>\nThe Company&#8217;s common stock is listed on NASDAQ under the ticker symbol &#8216;APDN,&#8217; and its publicly traded warrants are listed on OTC under the ticker symbol &#8216;APPDW.&#8217;\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Relations: <\/b>Sanjay M. Hurry, 917-733-5573, <a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#115;&#x61;&#110;&#x6a;&#97;&#x79;&#46;&#x68;u&#114;&#x72;&#121;&#x40;a&#x64;n&#x61;&#x73;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x73;&#97;&#x6e;&#106;a&#x79;&#46;h&#x75;&#114;&#x72;&#x79;&#64;&#x61;&#100;n&#x61;&#115;&#x2e;&#x63;o&#x6d;<\/a><br \/><b>Web:<\/b> <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.adnas.com&amp;esheet=53299558&amp;newsitemid=20230202005522&amp;lan=en-US&amp;anchor=www.adnas.com&amp;index=10&amp;md5=ae64a339bbe478623e60df8cdad58531\" rel=\"nofollow noopener\" shape=\"rect\">www.adnas.com<\/a><br \/><b>Twitter: <\/b>@APDN\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>STONY BROOK, N.Y.&#8211;(BUSINESS WIRE)&#8211;$APDN #LinearDNA&#8212;Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the \u201cCompany\u201d), a leader in polymerase chain reaction (&#8220;PCR&#8221;)-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023. The Company will host a conference call &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53578","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"STONY BROOK, N.Y.&#8211;(BUSINESS WIRE)&#8211;$APDN #LinearDNA&#8212;Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the \u201cCompany\u201d), a leader in polymerase chain reaction (&#8220;PCR&#8221;)-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023. The Company will host a conference call ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T15:03:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230202005522\/en\/593924\/21\/box-logo-businesswire.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023\",\"datePublished\":\"2023-02-02T15:03:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/\"},\"wordCount\":388,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005522\\\/en\\\/593924\\\/21\\\/box-logo-businesswire.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/\",\"name\":\"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005522\\\/en\\\/593924\\\/21\\\/box-logo-businesswire.jpg\",\"datePublished\":\"2023-02-02T15:03:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005522\\\/en\\\/593924\\\/21\\\/box-logo-businesswire.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005522\\\/en\\\/593924\\\/21\\\/box-logo-businesswire.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/","og_locale":"en_US","og_type":"article","og_title":"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 - Pharma Trend","og_description":"STONY BROOK, N.Y.&#8211;(BUSINESS WIRE)&#8211;$APDN #LinearDNA&#8212;Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the \u201cCompany\u201d), a leader in polymerase chain reaction (&#8220;PCR&#8221;)-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023. The Company will host a conference call ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-02T15:03:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230202005522\/en\/593924\/21\/box-logo-businesswire.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023","datePublished":"2023-02-02T15:03:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/"},"wordCount":388,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230202005522\/en\/593924\/21\/box-logo-businesswire.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/","url":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/","name":"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230202005522\/en\/593924\/21\/box-logo-businesswire.jpg","datePublished":"2023-02-02T15:03:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230202005522\/en\/593924\/21\/box-logo-businesswire.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230202005522\/en\/593924\/21\/box-logo-businesswire.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-report-first-quarter-fiscal-2023-financial-results-and-host-investor-conference-call-and-webcast-on-thursday-february-9-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53578"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53578\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}